Pharma

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mirabilis Medica, Inc., a privately-held medical device company, announced the initial closing of a $4 million Series A financing that will be used to complete development, testing and introduction of its image-guided High Intensity Focused Ultrasound (HIFU) system for treatment of gynecological diseases. The financing was co-led by Charter Life Sciences of Palo Alto and vSpring Capital of Salt Lake City

Today in Marketing/Media/ROI...keeping you current

Generic drugs dominate market, look to expand into biologics
Formulary , 12/16/09

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/15/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/15/09